FYR lands funding to find new biomarkers for Parkinson’s and beyond

Expanding from oncology into neurodegeneration, company leverages tiny extracellular vesicles to enhance blood-based biomarker discovery. Precision medicine biotech FYR Bio has closed an $8 million financing round to accelerate its expansion into neurodegenerative disease research, extending the company’s biomarker discovery platform beyond its roots in oncology. FYR’s shift into neurodegeneration underscores a broader push in […] The post FYR lands funding to find new biomarkers for Parkinson’s and beyond appeared first on Longevity.Technology.